(Q40655039)

22 September 2017

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

3 March 2023

1 reference

1 reference

R. G. Stoller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A302412

3 March 2023

K. R. Hande

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A302412

3 March 2023

S. A. Jacobs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A302412

3 March 2023

S. A. Rosenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A302412

3 March 2023

B. A. Chabner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A302412

3 March 2023

language of work or name

English

0 references

publication date

1 September 1977

1 reference

22 September 2017

22 September 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=302412

full work available at URL

3 March 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197709222971203

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

The New England Journal of Medicine

3 March 2023

published in

1 reference

22 September 2017

297

1 reference

22 September 2017

12

1 reference

22 September 2017

630-634

1 reference

Continuous infusion of methotrexate in children with acute leukemia

22 September 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

3 March 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

3 March 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

3 March 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

3 March 2023

Cancer Treatment Reports

5

61

745

Von

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Cancer chemotherapy reports

3 March 2023

6

6

19

Stoller

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate

3 March 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Cancer chemotherapy reports

3 March 2023

8

6

43

Pitman

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Methods in medical research

3 March 2023

9

10

297

Bertino

1964

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Competitive protein binding assay for methotrexate

3 March 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target Tissues

3 March 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

3 March 2023

Cancer Treatment Reports

13

61

751

Djerassi

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicity

3 March 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197709222971203

3 March 2023

Identifiers

1 reference

22 September 2017

1 reference